New York University School of Medicine
New York, 10016, United States
NCT Number: NCT02875054
Randomized control trial to evaluate uni-manual and bimanual upper limb function as well as compare outcomes of varied cast wear in children with hemiplegic cerebral palsy (CP) following a hybrid camp model of modified constraint induced movement therapy (mCIMT) and hand-arm bimanual intensive training (HABIT).
Looking for future studies?
Notify Me2 year–12 year
All sexes
Interventional
Not applicable
New York, 10016, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Involves forcing use of ones affected upper extremity (UE) by physically restraining the less affected upper extremity
Facilitates the translation of gains to improve goal-directed bimanual performance.
Time frame: 6 Months
parent questionnaire to determine how well and how often the family perceives the child Spontaneously uses their affected Upper Extremity throughout the day at home. This assessment is scored by adding up the parental score and getting an average score.
Time frame: 6 Months
Test of hand function in children with difficulties using one of their hands. The AHA measures how effectively the affected hand and arm is used in bimanual performance.
Time frame: 6 Months
Test of unilateral upper limb function is a validated and reliable tool for evaluating quality of upper limb movement in children with neurological conditions aged 2.5 to 15 years.
NYU Langone Health
Other
Camp High 5 2016: Evaluation of the Effect on Upper Limb Function
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04286191
Central Nervous System Diseases, Muscle Hypertonia
Charleston, South Carolina, United States
View Trial DetailsNCT04920890
Agnosia, COVID-19
Córdoba, Andalusia, Spain
View Trial DetailsNCT04160299
Cognition Disorders, Cognitive Dysfunction
Chicago, Illinois, United States
View Trial DetailsNCT05536921
Brain Damage, Chronic, Brain Diseases
Częstochowa, Poland
View Trial Details